Page last updated: 2024-12-05

methylphenazonium methosulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methylphenazonium methosulfate (MPS) is a synthetic compound with a phenazine core. It has been studied for its potential therapeutic uses, particularly in the treatment of neurological disorders. MPS is known to exhibit neuroprotective properties and has shown promise in preclinical models of Parkinson's disease, Alzheimer's disease, and stroke. Research suggests that MPS exerts its neuroprotective effects through various mechanisms, including antioxidant activity, inhibition of glutamate release, and modulation of intracellular signaling pathways. The synthesis of MPS typically involves the methylation of phenazonium salts. While promising, MPS is still in preclinical stages of development, and further research is needed to evaluate its safety and efficacy in humans. '

Methylphenazonium Methosulfate: Used as an electron carrier in place of the flavine enzyme of Warburg in the hexosemonophosphate system and also in the preparation of SUCCINIC DEHYDROGENASE. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9285
CHEBI ID8055
SCHEMBL ID94397
MeSH IDM0013659

Synonyms (58)

Synonym
5-methylphenazine methylsulfate
nsc-34661
5-methylphenazinium methyl sulfate
n-methylphenazonium methosulphate
5-methyl phenazine, methyl sulfate salt
nsc34661
5-n-methylphenazonium methosulfate
n-methylphenazinium methosulfate
phenazinium, methyl sulfate
n-methylphenazinium methyl sulfate
ccris 5618
einecs 206-072-1
pms (van)
pms (pharmaceutical)
nsc 34661
ai3-61076
phenazinium, 5-methyl-, methyl sulfate
n-methylphenazonium methosulfate
299-11-6
phenazine methosulfate
5-methylphenazinium methyl sulphate
C00200
phenazine methosulfate, >=90% (uv)
phenazine methosulphate
5-methylphenazin-5-ium methyl sulfate
methylphenazonium methosulfate
CHEBI:8055
phenazine methylsulfate
AKOS005146546
FT-0654557
P0083
phenazine methyl sulfate
n-methylphenazonium methyl sulfate
A820104
P1872
phenazinium, 5-methyl-, methyl sulfate (1:1)
unii-j3gyq3401y
j3gyq3401y ,
SCHEMBL94397
5-methylphenazinium methyl sulfate (1:1)
n-methylphenazonium methosulfate [mi]
DTXSID1059783
W-106967
mfcd00011923
CS-W004520
phenazine (methylsulfate)
5-methyl phenazinium methosulfate
RXGJTUSBYWCRBK-UHFFFAOYSA-M
DS-8261
Q27107674
AMY27098
CCG-267536
phenazin methosulfate
5-methylphenazin-5-ium;methyl sulfate
D82042
HY-W004520
n-methylphenazonium methosulfate(pms)
n-methylphenazonium methosulfate;5-methylphenazinium methyl sulfate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" It is concluded that Rib5P, generated in the oxidative segment of the PPP, is an important determinant of PPRibP synthesis in the lactating rat mammary gland and that insulin plays a central role in the regulation of the bioavailability of this precursor of nucleotide and nucleic acid synthesis."( Phosphoribosyl pyrophosphate and phosphoribosyl pyrophosphate synthetase in rat mammary gland. Changes in the lactation cycle and effects of diabetes, insulin and phenazine methosulphate.
Greenbaum, AL; Kunjara, S; McLean, P; Salih, N; Sochor, M, 1986
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves for PMS were similar for resident, elicited, or activated macrophages."( Destruction of Leishmania mexicana amazonensis amastigotes within macrophages in culture by phenazine methosulfate and other electron carriers.
Brunet, E; Dedet, JP; Rabinovitch, M; Robineaux, R; Ryter, A; Topper, G, 1982
)
0.26
" The biosensor was used to establish correlations of NTE inhibitions in blood with that in lymphocytes and brain after dosing hens with a neuropathic OP."( Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress.
Eremenko, AV; Kurochkin, IN; Makhaeva, GF; Malygin, VV; Richardson, RJ; Sigolaeva, LV; Sokolovskaya, LG; Strakhova, NN, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
azaheterocycle sulfate salt
phenazinesAny organonitrogen heterocyclic compound based on a phenazine skeleton and derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
aromatic biogenic amine degradation (bacteria)335
ammonia oxidation I (aerobic)924

Research

Studies (445)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990276 (62.02)18.7374
1990's79 (17.75)18.2507
2000's50 (11.24)29.6817
2010's33 (7.42)24.3611
2020's7 (1.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.09 (24.57)
Research Supply Index6.17 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.21%)6.00%
Case Studies1 (0.21%)4.05%
Observational0 (0.00%)0.25%
Other473 (99.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]